Active Not Recruiting OBSERVATIONAL NCT05184426

MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT) (LEONE-HT)

Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Conditions Antibody-mediated Rejection Heart Transplant Rejection Transplant Failure

Interventions Cardiac magnetic resonance Coronary angiography Echocardiogram Endomyocardial biopsy

Updated 4 times since 2022 Last updated: Jun 14, 2022 Started: Apr 1, 2021 Primary completion: Sep 30, 2024 Completion: Sep 30, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Antibody-mediated Rejection and Heart Transplant Rejection and is currently ongoing. Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Jul 2022 — Jul 2024 [monthly]

Active Not Recruiting
Feb 2022 — Jul 2022 [monthly]

Active Not Recruiting

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Juan Francisco Delgado Jimenez

Data source: Hospital Universitario 12 de Octubre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain
• Majadahonda, Spain